Debt-free Balance SheetZero financial leverage and a large equity base provide durable financial flexibility: the company can fund working capital, absorb shocks, and invest in capex or restructuring without refinancing risk. This lowers default risk and supports multi‑period strategic choices.

Strong Recent Revenue GrowthSustained top‑line expansion indicates demand traction or market share gains in specialty chemicals. If management converts revenue scale into more efficient absorption of fixed costs, this trend can underpin future margin improvement and returns on invested capital.

Positive EBITDA BaseA positive EBITDA suggests the core business can generate cash earnings before depreciation, amortization, and exceptional items. That provides a foundation to improve operating profit through SG&A discipline or cost optimization, enabling long‑term profitability recovery if sustained.

Bears Say

Persistent Negative Cash FlowRecurring negative OCF and FCF undermine self‑funding ability and increase dependence on external financing or asset sales. Over months, this raises execution risk for investments, constrains dividend capacity, and forces management to prioritize liquidity over growth unless cash generation reverses.

Near‑zero Gross MarginExtremely thin gross margins limit the company's ability to absorb SG&A, R&D, or rising input costs. Without structural pricing power or lower COGS, profitability will remain fragile and any adverse cost shock can push core operations deeper into loss over the medium term.

Very Low Return On EquityA negligible ROE on a substantial equity base signals capital inefficiency: shareholder capital is not being converted into profits. Persistently low ROE compresses shareholder value creation and makes future capital allocation decisions critical to avoid long‑term dilution or stagnation.

Uniphos Enterprises Limited News

Uniphos Enterprises Closes Trading Window Ahead of Unaudited Results

Uniphos Enterprises Limited ( ($IN:UNIENTER) ) has shared an announcement. Uniphos Enterprises Limited has announced that its trading...

2M ago

UNIENTER FAQ

What was Uniphos Enterprises Limited’s price range in the past 12 months?

Uniphos Enterprises Limited lowest stock price was ₹101.00 and its highest was ₹172.90 in the past 12 months.

What is Uniphos Enterprises Limited’s market cap?

Uniphos Enterprises Limited’s market cap is ₹8.17B.

When is Uniphos Enterprises Limited’s upcoming earnings report date?

Uniphos Enterprises Limited’s upcoming earnings report date is May 21, 2026 which is in 87 days.

How were Uniphos Enterprises Limited’s earnings last quarter?

Uniphos Enterprises Limited released its earnings results on Feb 06, 2026. The company reported -₹0.145 earnings per share for the quarter, missing the consensus estimate of N/A by -₹0.145.

Is Uniphos Enterprises Limited overvalued?

According to Wall Street analysts Uniphos Enterprises Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Uniphos Enterprises Limited pay dividends?

Uniphos Enterprises Limited pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.34%. See more information on Uniphos Enterprises Limited dividends here

What is Uniphos Enterprises Limited’s EPS estimate?

Uniphos Enterprises Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Uniphos Enterprises Limited have?

Uniphos Enterprises Limited has 69,545,845 shares outstanding.

What happened to Uniphos Enterprises Limited’s price movement after its last earnings report?

Uniphos Enterprises Limited reported an EPS of -₹0.145 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.663%.

Which hedge fund is a major shareholder of Uniphos Enterprises Limited?

Currently, no hedge funds are holding shares in IN:UNIENTER

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Uniphos Enterprises Limited

Uniphos Enterprises Limited engages in trading of chemicals and other products in India. The company also invests in quoted and unquoted securities. Uniphos Enterprises Limited was incorporated in 1969 and is based in Mumbai, India. Uniphos Enterprises Limited is a subsidiary of Nerka Chemicals Private Limited.